India's Pharmaceutical Exports

Country Profile

Ecuador

Ecuador is a growing market for Indian pharmaceuticals — $55.4M in FY 2025–26, with 3.4× growth over the past decade. Medicines accounts for 73% of shipments, with vaccines contributing $5.04M. The compound annual growth rate since FY2015 stands at 11.9%.

🇪🇨 $55.4M · 3.4× growth since FY2015 · 11.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$55.4M
Exports FY2025–26 DGCIS
3.4×
Growth FY2015→2026
11.9%
CAGR FY2015→2026
73%
Medicines Share
5
Product Categories Supplied
Ecuador is a growing market for Indian pharmaceuticals — $55.4M in FY 2025–26, with 3.4× growth over the past decade. Medicines accounts for 73% of shipments, with vaccines contributing $5.04M. The compound annual growth rate since FY2015 stands at 11.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $40.2M (72.6%) Surgical & Hospital Supplies $5.19M (9.4%) Vaccines $5.04M (9.1%) Medicine Ingredients $3.59M (6.5%) Traditional & Herbal $1.34M (2.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Ecuador in the RBI overseas direct investment dataset (2011–2026).